Skip to main content

Table 1 Characteristics of the study population

From: Aspirin 75 mg to prevent preeclampsia in high-risk pregnancies: a retrospective real-world study in China

Variables, n (%) or mean (SD)

LDA (n = 115)

Control (n = 151)

P

Maternal age (years)

31.99 (5.31)

32.38 (5.47)

0.5639

Delivery gestational age (week)

37.57 (1.73)

37.40 (1.91)

0.4543

Pre-pregnancy BMI (kg/m2)

25.81 (4.57)

24.19 (4.41)

0.0038

High risk factors

  

0.0560

 History of PE

3 (2.61%)

7 (4.64%)

0.5220

 Multiple pregnancy

24 (20.87%)

33 (21.85%)

0.8463

 Chronic hypertension

7 (6.09%)

3 (1.99%)

0.1065

 Pre-existing diabetes

11 (9.57%)

8 (5.30%)

0.1807

 Kidney disease

0 (0.00%)

3 (1.99%)

0.2610

 Autoimmune diseases

1 (0.87%)

0 (0.00%)

0.4323

Intermediate risk factors

  

0.1882

 Nulliparous

56 (48.70%)

77 (50.99%)

0.7104

 Obese (BMI ≥ 30 kg/m2)

26 (22.61%)

30 (19.87%)

0.5870

 Family history of PE

4 (3.48%)

6 (3.97%)

0.8334

 Age (≥ 35 years)

42 (36.52%)

72 (47.68%)

0.0684

Clinical indicators

 D-dimer (μg/L)

2273.90 (1212.50)

2476.60 (1827.30)

0.2790

 Platelet count (109/L)

197.00 (62.92)

195.80 (56.86)

0.8735

 Platelet aggregation rate (%)

70.30 (5.37)

67.89 (4.38)

0.0017

 Fibrinogen (g/L)

4.01 (0.82)

3.62 (0.69)

 < 0.0001

 Prothrombin time (s)

11.35 (0.89)

11.13 (0.87)

0.0504

 S/D value of uterine artery

2.31 (0.35)

2.29 (0.35)

0.5406

  1. LDA low-dose aspirin, BMI body mass index, PE preeclampsia, S/D systolic/diastolic